Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat-Reference-Cited by-同舟云学术

Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat

Published:2012-01-12 Issue:1 Volume:7 Page:e30134
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Takahashi Kazunori,Mizukami Hiroki,Kamata Kosuke,Inaba Wataru,Kato Noriaki,Hibi Chihiro,Yagihashi Soroku

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. The enigma of sepsis.;NC Riedmann;J Clin Invest,2003

2. Acute renal failure and sepsis.;RW Schrier;N Engl J Med,2004

3. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study.;MS Rangel-Fausto;JAMA,1995

4. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.;DC Angus;Crit Care Med,2001

5. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.;DG Remick;Shock,2000

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipopolysaccharide inhibits translation of iron chaperone PCBP1 to regulate inflammatory cytokine response in macrophage;Cytokine;2024-02

2. Proteomics-based screening of AKR1B1 as a therapeutic target and validation study for sepsis-associated acute kidney injury;PeerJ;2024-01-02

3. Lipopolysaccharide Impedes Bone Repair in FcγRIIB-Deficient Mice;International Journal of Molecular Sciences;2023-11-29

4. Combination Therapy with Resveratrol and Celastrol Using Folic Acid‐Functionalized Exosomes Enhances the Therapeutic Efficacy of Sepsis;Advanced Healthcare Materials;2023-08-11

5. Saroglitazar, a dual PPAR-α/γ agonist, alleviates LPS-induced hepatic and renal injury in rats;International Immunopharmacology;2023-02